Kim was appointed as Professor of Applied Dermatology Research at the University of Nottingham in August 2013, and is currently Co-Director of the Centre of Evidence Based Dermatology and Deputy Head of Division for the Divsion of Rheumatology, Orthopaedics and Dermatology..
She joined the unit in 1999 as a Research Associate, and was responsible for the design and conduct of a randomised controlled trial of topical corticosteroids for the treatment of eczema in children. Since then, Kim has worked in various roles within the unit, with a focus on independent randomised controlled trials (including conditions such as eczema, cellulitis, vitiligo, verrucae, and rare skin diseases).
Her particular interests are in the design and conduct of dermatology clinical trials, and in clinical trial methodology (especially outcomes research). She is a founder member of the UK Dermatology Clinical Trials Network, and is a member of the Executive Committee for the international Harmonizing Outcome Measures for Eczema (HOME) initiative.
Kim is a panel member for the National Institute for Health Research Programme Grants for Applied Research programme (NIHR PGfAR), is an adviser to the National Institute for Clinical Excellence (NICE), and an affiliate member of the National Institute for Health Research Health Technology Assessment (NIHR HTA) Commissioning Board.
- Clinical trial design and conduct
- Outcome measures
- Consensus methodologies
- Patient and public involvement
The Centre of Evidence Based Dermatology runs a popular 3-day annual course - Getting to grips with evidence-based dermatology.
Clinical trials in dermatology and clinical trial methodology (including outcomes research).
Current clinical trials and research projects:
CLOTHES: CLOTHing for the relief of Eczema Symptoms
HELP: Therapy for Erosive Lichen Planus trial (www.nottingham.ac.uk/dermatology)
STOP GAP: Study of Treatments for Pyoderma Gangrenosum Patients
NIHR Programme Grant Awards (SPRUSD): Setting Priorities and Reducing Uncertainties for the treatment and prevention of Skin Disease
HOME initiative: Harmonizing Outcome Measures for Eczema
THOMAS, K.S., CROOK, A.M., NUNN, A.J., FOSTER, K.A., MASON, J.M., CHALMERS, J.R., NASR, I.S., BRINDLE, R.J., ENGLISH, J., MEREDITH, S.K., REYNOLDS, N.J., DE BERKER D., MORTIMER, P.S. and WILLIAMS, H.C., 2013. Penicillin to prevent recurrent leg cellulitis New England Journal of Medicine. 368(18), 1695-1703 NANKERVIS, H., BAIBERGENOVA, A., WILLIAMS, H.C. and THOMAS, K.S., 2012. Prospective registration and outcome-reporting bias in randomized controlled trials of eczema treatments: a systematic review Journal of Investigative Dermatology. 132(12), 2727-2734
THOMAS, K.S., DEAN, T., O'LEARY, C., SACH, T.H., KOLLER, K., FROST, A., WILLIAMS, H.C. and SWET TRIAL TEAM, 2011. A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in children PLoS Medicine. 8(2), e1000395
Recently completed clinical trials:
SWET: Softened Water Eczema Trial (www.swet-trial.co.uk)
PATCH Cellulitis Trials: Prophylactic penicillin for the prevention of further episodes of cellulitis of the leg (PATCH I and II trials). (www.patchtrial.co.uk)
EVERT: Effective Verrucae Treatments (www.verrucatrial.co.uk)
Trials into the treatment and prevention of skin disease.